Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease

Csaba P Kovesdy1, Olga Kuchmak, Jun L Lu

  • 1Division of Nephrology, Salem VA Medical Center, 1970 Roanoke Boulevard, Salem, VA 24153, USA. csaba.kovesdy@va.gov

Insights

In non-dialysis-dependent chronic kidney disease (CKD), higher serum calcium correlates with long-term mortality, while lower calcium levels indicate increased short-term mortality risk.

Area of Science:

  • Nephrology
  • Cardiovascular Health
  • Mineral Metabolism

Background:

  • Elevated serum calcium is linked to higher mortality in dialysis patients.
  • The impact of serum calcium on mortality in non-dialysis-dependent chronic kidney disease (NDD CKD) is not well understood.
  • Outcomes associated with low serum calcium in NDD CKD require further characterization.

Purpose of the Study:

  • To investigate the association between serum calcium levels and all-cause mortality in patients with NDD CKD.
  • To differentiate the effects of baseline, time-varying, and time-averaged serum calcium on mortality.
  • To characterize outcomes related to both high and low serum calcium in this patient population.

Main Methods:

  • A historic prospective cohort study included 1243 men with moderate to advanced NDD CKD.
  • Cox proportional hazards models were utilized to analyze the associations.
  • Baseline, time-varying, and time-averaged serum calcium levels were examined in relation to all-cause mortality.

Main Results:

  • The relationship between serum calcium and mortality differed based on statistical modeling.
  • Higher baseline and time-averaged serum calcium were associated with increased long-term mortality.
  • Time-varying analyses revealed that lower serum calcium levels were linked to higher short-term mortality.

Conclusions:

  • Serum calcium levels have a dual association with mortality in NDD CKD patients: high levels for long-term, low levels for short-term.
  • These findings highlight the complex role of calcium in NDD CKD outcomes.
  • Further clinical trials are recommended to determine if normalizing serum calcium improves patient outcomes.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...